Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsFollow-on Biologics in the News - No. 4
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
By Donald Zuhn -- IPO Continues to Support 14-Year Exclusivity Period The Intellectual Property Owners Association (IPO), reporting on last week's announcement that the White House believes a 7-year data exclusivity period "strikes the appropriate balance between innovation and competition," reminded its members today that the IPO Board adopted a resolution in September 2008 supporting legislation that "promotes continued innovation by providing at least 14 years of data exclusivity for an innovator?s biological product with additional periods of exclusivity available for new indications and/or for approval for use in the pediatric population" (see "Follow-on Biologics in the News - No....Full post as published by Patent Docs on June 30, 2009 (boomark / email).
Lawsuits and Settlements
Murphy City, TX
$255,000 settlement in controversial pedophile news program case.
Newspaper Employees
Chinese Daily News must pay $5.19 million class action settlement for failing to pay overtime.
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Follow-On Biologics Bill Set To Try Again
New Rules On Generic Biological Medicines Under US Congressional Debate
Claim Construction in Exonhit Therapeutics v. Jivan Biologics
Economist Argues That 7 Years Ought to be Enough for Biologic Data Exclusivity
Follow-On Biologics: Poll Shows (Surprise) Consumers Want Cheaper Drugs









